Annual EBITDA:
-$353.72M-$117.85M(-49.96%)Summary
- As of today, IONS annual EBITDA is -$353.72 million, with the most recent change of -$117.85 million (-49.96%) on December 31, 2024.
- During the last 3 years, IONS annual EBITDA has fallen by -$348.53 million (-6718.06%).
- IONS annual EBITDA is now -196.33% below its all-time high of $367.20 million, reached on December 31, 2019.
Performance
IONS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$150.23M+$270.24M(+225.19%)Summary
- As of today, IONS quarterly EBITDA is $150.23 million, with the most recent change of +$270.24 million (+225.19%) on June 30, 2025.
- Over the past year, IONS quarterly EBITDA has increased by +$188.07 million (+497.06%).
- IONS quarterly EBITDA is now -34.88% below its all-time high of $230.70 million, reached on December 31, 2021.
Performance
IONS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$167.65M+$188.07M(+52.87%)Summary
- As of today, IONS TTM EBITDA is -$167.65 million, with the most recent change of +$188.07 million (+52.87%) on June 30, 2025.
- Over the past year, IONS TTM EBITDA has increased by +$77.85 million (+31.71%).
- IONS TTM EBITDA is now -145.66% below its all-time high of $367.20 million, reached on December 31, 2019.
Performance
IONS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IONS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -50.0% | +497.1% | +31.7% |
| 3Y3 Years | -6718.1% | +254.9% | -5868.2% |
| 5Y5 Years | -196.3% | +618.0% | -251.9% |
IONS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -6718.1% | at low | at high | +225.2% | -585.3% | +52.9% |
| 5Y | 5-Year | -196.3% | at low | -34.9% | +225.2% | -251.9% | +52.9% |
| All-Time | All-Time | -196.3% | at low | -34.9% | +225.2% | -145.7% | +52.9% |
IONS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $150.23M(+225.2%) | -$167.65M(+52.9%) |
| Mar 2025 | - | -$120.00M(-49.1%) | -$355.72M(-1.0%) |
| Dec 2024 | -$353.72M(-50.0%) | -$80.50M(+31.4%) | -$352.23M(-42.0%) |
| Sep 2024 | - | -$117.38M(-210.2%) | -$248.03M(-1.0%) |
| Jun 2024 | - | -$37.84M(+67.5%) | -$245.50M(+5.4%) |
| Mar 2024 | - | -$116.52M(-591.8%) | -$259.48M(-10.7%) |
| Dec 2023 | -$235.87M(-3.6%) | $23.69M(+120.6%) | -$234.47M(+19.1%) |
| Sep 2023 | - | -$114.84M(-121.6%) | -$289.74M(-34.3%) |
| Jun 2023 | - | -$51.81M(+43.4%) | -$215.72M(+17.3%) |
| Mar 2023 | - | -$91.51M(-189.8%) | -$260.90M(-14.6%) |
| Dec 2022 | -$227.76M(-4290.1%) | -$31.58M(+22.6%) | -$227.74M(-759.3%) |
| Sep 2022 | - | -$40.81M(+57.9%) | $34.54M(+1329.7%) |
| Jun 2022 | - | -$96.99M(-66.2%) | -$2.81M(-114.3%) |
| Mar 2022 | - | -$58.35M(-125.3%) | $19.65M(+464.9%) |
| Dec 2021 | -$5.19M(+95.3%) | $230.70M(+395.1%) | -$5.38M(+97.8%) |
| Sep 2021 | - | -$78.17M(-4.9%) | -$246.97M(-27.7%) |
| Jun 2021 | - | -$74.53M(+10.6%) | -$193.47M(-30.8%) |
| Mar 2021 | - | -$83.38M(-666.1%) | -$147.94M(-32.2%) |
| Dec 2020 | -$111.19M(-130.3%) | -$10.88M(+55.9%) | -$111.90M(-201.4%) |
| Sep 2020 | - | -$24.67M(+14.9%) | $110.36M(-28.4%) |
| Jun 2020 | - | -$29.00M(+38.7%) | $154.22M(-15.4%) |
| Mar 2020 | - | -$47.34M(-122.4%) | $182.31M(-50.4%) |
| Dec 2019 | $367.20M(+2049.1%) | $211.37M(+1000.9%) | $367.20M(+102.2%) |
| Sep 2019 | - | $19.20M(+2187.0%) | $181.57M(+15.7%) |
| Jun 2019 | - | -$920.00K(-100.7%) | $157.00M(+35.6%) |
| Mar 2019 | - | $137.55M(+434.3%) | $115.77M(+714.6%) |
| Dec 2018 | -$18.84M(-151.8%) | $25.75M(+578.7%) | -$18.84M(+61.7%) |
| Sep 2018 | - | -$5.38M(+87.2%) | -$49.13M(-33.2%) |
| Jun 2018 | - | -$42.15M(-1530.3%) | -$36.90M(-322.5%) |
| Mar 2018 | - | $2.95M(+164.8%) | $16.59M(-54.4%) |
| Dec 2017 | $36.34M(+477.0%) | -$4.55M(-166.4%) | $36.34M(-66.4%) |
| Sep 2017 | - | $6.86M(-39.5%) | $108.05M(-10.4%) |
| Jun 2017 | - | $11.33M(-50.1%) | $120.56M(+88.3%) |
| Mar 2017 | - | $22.70M(-66.2%) | $64.04M(+764.4%) |
| Dec 2016 | -$9.64M(+76.5%) | $67.16M(+246.7%) | -$9.64M(+92.9%) |
| Sep 2016 | - | $19.37M(+142.9%) | -$135.88M(+24.2%) |
| Jun 2016 | - | -$45.19M(+11.4%) | -$179.17M(-108.9%) |
| Mar 2016 | - | -$50.98M(+13.7%) | -$85.78M(-109.5%) |
| Dec 2015 | -$40.94M(-79.7%) | -$59.08M(-146.9%) | -$40.94M(-194.2%) |
| Sep 2015 | - | -$23.93M(-149.6%) | $43.45M(-12.2%) |
| Jun 2015 | - | $48.20M(+886.0%) | $49.52M(+2010.5%) |
| Mar 2015 | - | -$6.13M(-124.2%) | -$2.59M(+88.6%) |
| Dec 2014 | -$22.78M(+39.1%) | $25.31M(+241.7%) | -$22.78M(+64.7%) |
| Sep 2014 | - | -$17.86M(-356.9%) | -$64.59M(+6.7%) |
| Jun 2014 | - | -$3.91M(+85.1%) | -$69.22M(+0.2%) |
| Mar 2014 | - | -$26.32M(-59.5%) | -$69.36M(-85.3%) |
| Dec 2013 | -$37.42M(+12.3%) | -$16.50M(+26.6%) | -$37.42M(-37.9%) |
| Sep 2013 | - | -$22.49M(-455.3%) | -$27.14M(+26.8%) |
| Jun 2013 | - | -$4.05M(-172.1%) | -$37.06M(-27.8%) |
| Mar 2013 | - | $5.62M(+190.3%) | -$29.00M(+45.7%) |
| Dec 2012 | -$42.68M(+24.2%) | -$6.22M(+80.8%) | -$53.44M(+14.0%) |
| Sep 2012 | - | -$32.41M(-907.8%) | -$62.14M(-19.9%) |
| Jun 2012 | - | $4.01M(+121.3%) | -$51.84M(+26.3%) |
| Mar 2012 | - | -$18.81M(-26.0%) | -$70.29M(-3.3%) |
| Dec 2011 | -$56.27M(-45.2%) | -$14.93M(+32.5%) | -$68.06M(-7.0%) |
| Sep 2011 | - | -$22.11M(-53.1%) | -$63.63M(-25.7%) |
| Jun 2011 | - | -$14.44M(+12.9%) | -$50.63M(+12.8%) |
| Mar 2011 | - | -$16.58M(-57.9%) | -$58.08M(-21.2%) |
| Dec 2010 | -$38.75M(-295.8%) | -$10.50M(-15.2%) | -$47.93M(+1.6%) |
| Sep 2010 | - | -$9.12M(+58.4%) | -$48.69M(-0.6%) |
| Jun 2010 | - | -$21.89M(-240.9%) | -$48.42M(-78.9%) |
| Mar 2010 | - | -$6.42M(+43.0%) | -$27.06M(-41.7%) |
| Dec 2009 | -$9.79M(-338.2%) | -$11.26M(-27.4%) | -$19.09M(-33.0%) |
| Sep 2009 | - | -$8.84M(-1546.7%) | -$14.36M(-667.8%) |
| Jun 2009 | - | -$537.00K(-134.6%) | -$1.87M(-191.2%) |
| Mar 2009 | - | $1.55M(+123.7%) | $2.05M(+175.8%) |
| Dec 2008 | $4.11M(+115.7%) | -$6.53M(-279.1%) | -$2.71M(-292.3%) |
| Sep 2008 | - | $3.64M(+7.7%) | $1.41M(-82.0%) |
| Jun 2008 | - | $3.38M(+205.5%) | $7.82M(+151.4%) |
| Mar 2008 | - | -$3.21M(-32.8%) | -$15.22M(+53.8%) |
| Dec 2007 | -$26.15M | -$2.41M(-124.0%) | -$32.92M(+25.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | $10.06M(+151.2%) | -$44.42M(+39.2%) |
| Jun 2007 | - | -$19.66M(+5.9%) | -$73.02M(-3.3%) |
| Mar 2007 | - | -$20.90M(-50.2%) | -$70.68M(-7.5%) |
| Dec 2006 | -$58.54M(-46.9%) | -$13.91M(+25.0%) | -$65.75M(-8.0%) |
| Sep 2006 | - | -$18.54M(-7.1%) | -$60.87M(-11.0%) |
| Jun 2006 | - | -$17.32M(-8.4%) | -$54.82M(-10.1%) |
| Mar 2006 | - | -$15.98M(-76.9%) | -$49.78M(+0.9%) |
| Dec 2005 | -$39.84M(+45.6%) | -$9.03M(+27.7%) | -$50.22M(+17.1%) |
| Sep 2005 | - | -$12.49M(-1.8%) | -$60.56M(+14.0%) |
| Jun 2005 | - | -$12.27M(+25.3%) | -$70.45M(+11.4%) |
| Mar 2005 | - | -$16.42M(+15.2%) | -$79.51M(+6.9%) |
| Dec 2004 | -$73.26M(-12.8%) | -$19.37M(+13.4%) | -$85.43M(+2.4%) |
| Sep 2004 | - | -$22.38M(-4.9%) | -$87.53M(-3.9%) |
| Jun 2004 | - | -$21.34M(+4.5%) | -$84.22M(-4.5%) |
| Mar 2004 | - | -$22.34M(-4.0%) | -$80.60M(-4.4%) |
| Dec 2003 | -$64.92M(-62.2%) | -$21.48M(-12.7%) | -$77.18M(-17.7%) |
| Sep 2003 | - | -$19.07M(-7.6%) | -$65.57M(-2.4%) |
| Jun 2003 | - | -$17.72M(+6.3%) | -$64.01M(-9.2%) |
| Mar 2003 | - | -$18.91M(-91.6%) | -$58.63M(-18.6%) |
| Dec 2002 | -$40.02M(-2.3%) | -$9.87M(+43.6%) | -$49.44M(-4.6%) |
| Sep 2002 | - | -$17.51M(-41.9%) | -$47.26M(-37.1%) |
| Jun 2002 | - | -$12.34M(-27.0%) | -$34.46M(+10.7%) |
| Mar 2002 | - | -$9.72M(-26.3%) | -$38.59M(+16.3%) |
| Dec 2001 | -$39.13M(-66.9%) | -$7.70M(-63.5%) | -$46.10M(+4.8%) |
| Sep 2001 | - | -$4.71M(+71.4%) | -$48.42M(-11.3%) |
| Jun 2001 | - | -$16.46M(+4.5%) | -$43.50M(-23.5%) |
| Mar 2001 | - | -$17.23M(-72.1%) | -$35.22M(-21.5%) |
| Dec 2000 | -$23.45M(+38.1%) | -$10.01M(-4960.2%) | -$28.99M(+7.9%) |
| Sep 2000 | - | $206.00K(+102.5%) | -$31.48M(+20.9%) |
| Jun 2000 | - | -$8.18M(+25.7%) | -$39.78M(+8.8%) |
| Mar 2000 | - | -$11.01M(+11.9%) | -$43.61M(-1.2%) |
| Dec 1999 | -$37.90M(-34.4%) | -$12.50M(-54.3%) | -$43.10M(-6.9%) |
| Sep 1999 | - | -$8.10M(+32.5%) | -$40.30M(-29.6%) |
| Jun 1999 | - | -$12.00M(-14.3%) | -$31.10M(+3.1%) |
| Mar 1999 | - | -$10.50M(-8.2%) | -$32.10M(+1.5%) |
| Dec 1998 | -$28.20M(-0.4%) | -$9.70M(-981.8%) | -$32.60M(+1.8%) |
| Sep 1998 | - | $1.10M(+108.5%) | -$33.20M(+10.0%) |
| Jun 1998 | - | -$13.00M(-18.2%) | -$36.90M(-9.8%) |
| Mar 1998 | - | -$11.00M(-6.8%) | -$33.60M(-6.7%) |
| Dec 1997 | -$28.10M(-6.0%) | -$10.30M(-296.2%) | -$31.50M(-2.6%) |
| Sep 1997 | - | -$2.60M(+73.2%) | -$30.70M(+11.8%) |
| Jun 1997 | - | -$9.70M(-9.0%) | -$34.80M(-4.8%) |
| Mar 1997 | - | -$8.90M(+6.3%) | -$33.20M(-14.1%) |
| Dec 1996 | -$26.50M(-16.2%) | -$9.50M(-41.8%) | -$29.10M(-12.8%) |
| Sep 1996 | - | -$6.70M(+17.3%) | -$25.80M(+2.6%) |
| Jun 1996 | - | -$8.10M(-68.8%) | -$26.50M(-8.6%) |
| Mar 1996 | - | -$4.80M(+22.6%) | -$24.40M(+5.1%) |
| Dec 1995 | -$22.80M(-22.6%) | -$6.20M(+16.2%) | -$25.70M(+16.3%) |
| Sep 1995 | - | -$7.40M(-23.3%) | -$30.70M(-8.5%) |
| Jun 1995 | - | -$6.00M(+1.6%) | -$28.30M(-4.4%) |
| Mar 1995 | - | -$6.10M(+45.5%) | -$27.10M(-6.3%) |
| Dec 1994 | -$18.60M(-23.2%) | -$11.20M(-124.0%) | -$25.50M(-36.4%) |
| Sep 1994 | - | -$5.00M(-4.2%) | -$18.70M(-3.3%) |
| Jun 1994 | - | -$4.80M(-6.7%) | -$18.10M(-1.1%) |
| Mar 1994 | - | -$4.50M(-2.3%) | -$17.90M(+3.2%) |
| Dec 1993 | -$15.10M(+23.0%) | -$4.40M(0.0%) | -$18.50M(+11.5%) |
| Sep 1993 | - | -$4.40M(+4.3%) | -$20.90M(-0.5%) |
| Jun 1993 | - | -$4.60M(+9.8%) | -$20.80M(-4.5%) |
| Mar 1993 | - | -$5.10M(+25.0%) | -$19.90M(-2.1%) |
| Dec 1992 | -$19.60M(-104.2%) | -$6.80M(-58.1%) | -$19.50M(-11.4%) |
| Sep 1992 | - | -$4.30M(-16.2%) | -$17.50M(-15.1%) |
| Jun 1992 | - | -$3.70M(+21.3%) | -$15.20M(-11.8%) |
| Mar 1992 | - | -$4.70M(+2.1%) | -$13.60M(-34.7%) |
| Dec 1991 | -$9.60M(-134.1%) | -$4.80M(-140.0%) | -$10.10M(+10.6%) |
| Sep 1991 | - | -$2.00M(+4.8%) | -$11.30M(-28.4%) |
| Jun 1991 | - | -$2.10M(-75.0%) | -$8.80M(-41.9%) |
| Mar 1991 | - | -$1.20M(+80.0%) | -$6.20M(-37.8%) |
| Dec 1990 | -$4.10M | -$6.00M(-1300.0%) | -$4.50M(-400.0%) |
| Sep 1990 | - | $500.00K(0.0%) | $1.50M(+50.0%) |
| Jun 1990 | - | $500.00K(0.0%) | $1.00M(+100.0%) |
| Mar 1990 | - | $500.00K | $500.00K |
FAQ
- What is Ionis Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Ionis Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Ionis Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Ionis Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of IONS is -$353.72M
What is the all-time high annual EBITDA for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high annual EBITDA is $367.20M
What is Ionis Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, IONS annual EBITDA has changed by -$117.85M (-49.96%)
What is Ionis Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of IONS is $150.23M
What is the all-time high quarterly EBITDA for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high quarterly EBITDA is $230.70M
What is Ionis Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, IONS quarterly EBITDA has changed by +$188.07M (+497.06%)
What is Ionis Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of IONS is -$167.65M
What is the all-time high TTM EBITDA for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high TTM EBITDA is $367.20M
What is Ionis Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, IONS TTM EBITDA has changed by +$77.85M (+31.71%)